Substances · Lysergamides
1V-LSD
- Preferred name
- 1V-LSD
- IUPAC name
- (6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
- Parent CAS number (reference)
- 2767597-51-1
- Molecular formula
- C25H33N3O2
- Molecular weight
- 407.5 g/mol
- InChIKey
- GIIBVGJWUZNECE-XMSQKQJNSA-N
- PubChem
- CID 162368540
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
1-Valeroyl-LSD Valerie 1VLSD 1V LSD
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
1V-LSD
Receptor Telemetry & Mechanism of Action
Lipophilic N1-pentanoyl prodrug cleaved in serum to LSD-25 (~79% molar mass equivalent of LSD-25).
Biotransformation & Active Metabolites
Hydrolyzes to LSD and valeric acid in human serum.
Temporal Pharmacokinetics
N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist) — Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.
- Onset 45–120 min
- Peak Window 2.5–4.5 h
- Total Window 8–12 h
- Residual / Half-Life 4–8 h residual wakefulness
Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
20–30 ug
Subtle threshold receptor activity (N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist)).
Minimal baseline autonomic shift.
30–90 ug
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
90–175 ug
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
175–320 ug
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
320+ ug
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Strongly documented to provoke acute tonic-clonic seizures, fugue states, and severe psychotic episodes with lysergamides.
Lowers seizure threshold alongside 5-HT2A excitation.
Elevated Hazard — Avoid
Exponentially amplifies thought loops, tachycardia, anxiety, and acute paranoia.
Caution / Receptor Attenuation
Chronic SSRIs and acute benzodiazepines markedly attenuate 5-HT2A perceptual effects.
Structural Isomer & Sibling Comparison
Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.
Physicochemical Stability & Storage
Form: Clear, colorless calibrated liquid solution for microgram (µg) volumetric measurement. · Supplied pre-dissolved in analytical carrier; sensitive to chlorine/tap water.
Highly sensitive to UV light, heat, and chlorine; store airtight in amber glass under cold/refrigerated conditions.
Cross-Tolerance & Dependence Profile
Immediate rapid 5-HT2A receptor downregulation within hours, cross-tolerant with all tryptamines and phenethylamines; baseline sensitivity typically resets over 10–14 days. Non-addictive physiologically.
Chemical Architecture & Structural Profile
1V-LSD ((6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide) is a reference compound belonging to the Lysergamides class, characterized by the molecular formula C25H33N3O2 and a molar mass of 407.5 g/mol. The parent molecule is indexed under CAS registry number 2767597-51-1 and in the NCBI PubChem database as CID 162368540 (Standard InChIKey: GIIBVGJWUZNECE-XMSQKQJNSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 1V-LSD is indexed within the Lysergamides structural group. Toxicological notes (PsychonautWiki): extremely low toxicity relative to dose. Dependence liability (PsychonautWiki): non-addictive with a low abuse potential. Documented cross-tolerance class: psychedelic. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (IE) — National Regulatory Authority (IE) (2026-11-12)